Related Experiment Video
Updated: May 7, 2026
Testing the Vascular Invasive Ability of Cancer Cells in Zebrafish Danio Rerio
Published on: November 3, 2016
Calcium and cancer metastasis: Discoveries from zebrafish xenografts
Ghazala Rahman1, Anamika Bhargava1
1Department of Biotechnology, Indian Institute of Technology Hyderabad (IITH), Kandi, Sangareddy 502284, Telangana, India.
Abstract:
Cancer metastasis remains the leading cause of cancer-related deaths, highlighting the urgent need for therapies targeting metastatic processes. Dysregulated calcium (Ca2+) signaling is increasingly linked to metastasis and offers a promising, underexplored therapeutic target. The zebrafish xenograft model has emerged as a powerful tool for studying cancer due to its optical transparency, genetic similarity to humans, and rapid development. This review outlines how zebrafish xenografts have been employed to investigate Ca2+ signaling in cancer progression, revealing roles for ORAI1 in nasopharyngeal carcinoma, TRPM8 in prostate cancer, VDAC1 and TMBIM6 in breast cancer, and TRPV1 in gastric cancer. These studies highlight the zebrafish xenograft model's advantages in visualization, cost, and throughput over traditional systems. Despite its promise, the zebrafish xenograft model remains underutilized in Ca2+-related metastasis research. Future work using transgenic lines like tg-EGFP:flk1 and tg-GCaMP, CRISPR knockouts, morpholinos or optogenetic approaches could unlock deeper insights and guide novel metastasis-targeting therapies.
Insights
Cancer metastasis is a major cause of death, but targeting calcium (Ca2+) signaling offers new hope. Zebrafish xenografts effectively visualize Ca2+ roles in metastasis for developing novel therapies.
Area of Science:
- Oncology
- Molecular Biology
- Biophysics
Background:
- Cancer metastasis is the primary cause of cancer-related mortality, necessitating novel therapeutic strategies.
- Aberrant calcium (Ca2+) signaling is implicated in cancer progression and metastasis, presenting a potential therapeutic target.
- The zebrafish xenograft model offers unique advantages for in vivo cancer research due to its optical transparency and genetic tractability.
Purpose of the Study:
- To review the application of zebrafish xenograft models in studying calcium (Ca2+) signaling in cancer metastasis.
- To highlight specific ion channels and proteins involved in Ca2+-mediated metastasis across various cancer types.
- To underscore the potential of zebrafish models for advancing metastasis research and therapeutic development.
Main Methods:
- Literature review of studies utilizing zebrafish xenografts to investigate Ca2+ signaling in cancer.
- Analysis of findings linking specific Ca2+ channels (ORAI1, TRPM8, TRPV1) and proteins (VDAC1, TMBIM6) to metastasis in different cancers.
- Evaluation of the zebrafish xenograft model's advantages in visualization, cost-effectiveness, and experimental throughput.
Main Results:
- Zebrafish xenografts have identified key roles for ORAI1 in nasopharyngeal carcinoma, TRPM8 in prostate cancer, VDAC1 and TMBIM6 in breast cancer, and TRPV1 in gastric cancer metastasis.
- These studies demonstrate the zebrafish model's efficacy in visualizing dynamic Ca2+ signaling events during cancer cell invasion and metastasis.
- The model provides a cost-effective and high-throughput platform compared to traditional cancer research systems.
Conclusions:
- Zebrafish xenograft models are valuable tools for dissecting the complex roles of Ca2+ signaling in cancer metastasis.
- Further research employing advanced zebrafish techniques (transgenic lines, CRISPR, optogenetics) can deepen our understanding and guide the development of new anti-metastasis therapies.
- Despite its utility, the zebrafish xenograft model remains underutilized in Ca2+-related metastasis research, indicating a need for broader adoption.
